GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Price-to-Owner-Earnings

SLS BIO Co (XKRX:246250) Price-to-Owner-Earnings : 12.06 (As of May. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co Price-to-Owner-Earnings?

As of today (2024-05-25), SLS BIO Co's share price is ₩4810.00. SLS BIO Co's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₩398.71. It's Price-to-Owner-Earnings for today is 12.06.


The historical rank and industry rank for SLS BIO Co's Price-to-Owner-Earnings or its related term are showing as below:

XKRX:246250' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.33   Med: 55.9   Max: 175.47
Current: 12.45

During the past 9 years, the highest Price-to-Owner-Earnings of SLS BIO Co was 175.47. The lowest was 10.33. And the median was 55.90.


XKRX:246250's Price-to-Owner-Earnings is ranked better than
78.46% of 65 companies
in the Medical Diagnostics & Research industry
Industry Median: 24.65 vs XKRX:246250: 12.45

As of today (2024-05-25), SLS BIO Co's share price is ₩4810.00. SLS BIO Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩77.42. Therefore, SLS BIO Co's PE Ratio for today is 62.13.

As of today (2024-05-25), SLS BIO Co's share price is ₩4810.00. SLS BIO Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩77.42. Therefore, SLS BIO Co's PE Ratio without NRI for today is 62.13.

During the past 9 years, SLS BIO Co's highest PE Ratio without NRI was 92.17. The lowest was 22.20. And the median was 62.13.


SLS BIO Co Price-to-Owner-Earnings Historical Data

The historical data trend for SLS BIO Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co Price-to-Owner-Earnings Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only 81.07 - 67.89 12.48 -

SLS BIO Co Quarterly Data
Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial 12.48 - - - -

Competitive Comparison of SLS BIO Co's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, SLS BIO Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SLS BIO Co's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SLS BIO Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where SLS BIO Co's Price-to-Owner-Earnings falls into.



SLS BIO Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

SLS BIO Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=4810.00/398.71
=12.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SLS BIO Co  (XKRX:246250) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


SLS BIO Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


SLS BIO Co (XKRX:246250) Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines